Search Results
Dec 01, 2025, 11:21 ET Generate:Biomedicines lance des essais mondiaux de phase 3 sur le GB-0895, un anticorps anti-TSLP à longue durée d'action pour le traitement de l'asthme sévère, conçu grâce à l'IA
progrès significatifs de la médecine respiratoire, l'asthme sévère reste difficile à contrôler pour de nombreuses personnes », a déclaré le Dr Laurie Lee, médecin-chef du département Immunologie et Inflammation chez Generate:Biomedicines. « L'initiation des essais de phase 3 pour le GB-0895 reflète à la
More news about: Generate:Biomedicines
Dec 01, 2025, 10:46 ET Generate:Biomedicines rozpoczyna globalne badania III fazy nad GB-0895, przeciwciałem o długim działaniu skierowanym przeciwko limfopoetynie zrębu grasicy (TSLP) przeznaczonym do leczenia astmy ciężkiej, opracowanym przy użyciu sztucznej inteligencji
lat".„Pomimo znacznych postępów w medycynie chorób układu oddechowego, astma ciężka nadal pozostaje trudna do opanowania dla wielu osób - powiedziała dr Laurie Lee, dyrektor medyczny ds. immunologii i stanów zapalnych w Generate:Biomedicines. - Rozpoczęcie badań III fazy nad GB-0895 odzwierciedla zarówno nasze zaangażowanie
More news about: Generate:Biomedicines
Dec 01, 2025, 10:09 ET LG HONORS COACHES FOR MENTAL HEALTH ADVOCACY WITH SECOND ANNUAL LIFE'S GOOD COACHES AWARD
fostering a safe and positive environment."At LG, we believe in the profound ability of sports to unite people and inspire hope," said Jeannie Lee, director of corporate marketing at LG US. "This is an unprecedented time at the intersection of mental health and sports. The LG Life's Good Coaches
More news about: LG Electronics USA
Dec 01, 2025, 09:00 ET Jack Henry Study Uncovers Gaps in Consumer Financial Confidence and Digital Experience
how to meet them where they are – but few have clarity on the distinctive behavioral and attitudinal sub-segments within and across generations," said Lee Wetherington, senior director of corporate strategy at Jack Henry. "This study's nuanced insights help identify the digital capabilities that most influence
More news about: Jack Henry & Associates, Inc.
Dec 01, 2025, 08:30 ET BitMine Immersion (BMNR) Announces ETH Holdings Reach 3.73 Million Tokens, and Total Crypto and Cash Holdings of $12.1 Billion
investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support BitMine's goal of acquiring 5% of ETHLAS VEGAS, Dec.
More news about: BitMine Immersion Technologies, Inc.
Dec 01, 2025, 08:00 ET Daesang to Participate in "FiE 2025" in Paris, Strengthening Global Ingredient Competitiveness
applications, has low viscosity, and dissolves easily even in cold water, enabling its use in across a wide range of manufacturing processes.Lee Hyo-hoon, Head of Ingredient Marketing at Daesang, said, "This global ingredient exhibition offers an important opportunity to showcase the strength
More news about: Daesang Corporation
Dec 01, 2025, 06:00 ET Generate:Biomedicines 將啟動 GB-0895 全球三期臨床試驗，此為運用人工智能科技研發的長效抗 TSLP 抗體，專治嚴重哮喘
及其領域而言皆為重要里程碑。此舉彰顯了可編程生物學的潛力——能以前所未有的速度與精準度為病人設計最佳分子解決方案。本案例具體展現了透過人工智能改造的抗體，如何在短短四年內達成潛在同類最佳特性，並成功進入第三期臨床研究階段。」Generate:Biomedicines 免疫學和炎症醫學主任 Laurie Lee 表示：「儘管呼吸醫學取得顯著進展，許多人仍難以有效控制嚴重哮喘症狀。啟動 GB-0895 的第三期臨床試驗，既體現我們對嚴重哮喘病人的承諾，也彰顯我們研發平台的實力——致力開發能減輕慢性呼吸道疾病負擔的藥物。」在 ERS 2025 上發表的第一期試驗結果 University
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET 제너레이트 바이오메디슨, AI 설계 장기 지속형 항-TSLP 항체 'GB-0895' 글로벌 3상 시험 착수
바이올로지가 환자를 위한 최적의 분자 솔루션을 전례 없는 속도와 정교함으로 설계할 수 있음을 보여준다. 이번 사례는 AI로 설계된 항체가 불과 4년 만에 업계 최고 수준의 프로파일을 달성하고 3상까지 진입할 수 있음을 입증한다"라고 말했다.로리 리(Laurie Lee, MD) 제너레이트 바이오메디슨 면역 및 염증 분야 최고의학책임자(CMO)는 "호흡기 의학 분야의 상당한 발전에도 불구하고 중증 천식은 여전히 많은 환자에게 조절하기 어려운 질병으로 남아 있다"며 "GB-0895의 3상 개시는 중증 천식 환자에 대한 우리의 헌신과 만성
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines spúšťa globálne štúdie 3. fázy liečiva GB-0895 - anti-TSLP protilátky s dlhým pôsobením na liečbu ťažkej astmy, vyvinutej pomocou AI
štyri roky."„Napriek významnému pokroku v respiračnej medicíne je pre mnohých ľudí stále ťažké udržať ťažkú astmu pod kontrolou," povedala Laurie Lee, MD, hlavná lekárka pre imunológiu a zápaly v Generate:Biomedicines. „Spustenie štúdií 3. fázy pre GB-0895 odráža náš záväzok voči ľuďom žijúcim s ťažkou
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines начинает 3 фазу глобальных клинических испытаний разработанного с использованием ИИ препарата GB-0895 -- антитела длительного действия, направленного на блокировку TSLP при тяжелых случаях астмы
достижения в области респираторной медицины, для многих людей контролировать тяжелые случаи астмы по-прежнему очень трудно», — сказал Лори Ли (Laurie Lee), доктор медицинских наук, главный врач подразделения иммунологии и воспалений в Generate:Biomedicines. «Начало 3 фазы исследований GB-0895 отражает как
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
just four years.""Despite significant advances in respiratory medicine, severe asthma remains difficult to control for many people," said Laurie Lee, MD, chief medical officer for immunology & inflammation at Generate:Biomedicines. "Initiating Phase 3 studies for GB-0895 reflects both our commitment
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines Memulai Penelitian Fase 3 Global Tentang GB-0895, Antibodi Anti-TSLP Kerja Lambat yang Direkayasa AI Untuk Asma Berat
tahun.""Meskipun pengobatan penyakit pernapasan mencapai kemajuan signifikan, penyakit asma berat masih sulit dikendalikan banyak orang," kata Laurie Lee, MD, Chief Medical Officer bidang Imunologi & Inflamasi di Generate:Biomedicines. "Memulai penelitian GB-0895 Fase 3 menunjukkan komitmen kami terhadap
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
just four years.""Despite significant advances in respiratory medicine, severe asthma remains difficult to control for many people," said Laurie Lee, MD, chief medical officer for immunology & inflammation at Generate:Biomedicines. "Initiating Phase 3 studies for GB-0895 reflects both our commitment
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines startet globale Phase-3-Studien mit GB-0895, einem langwirksamen Anti-TSLP-Antikörper für schweres Asthma, der mit KI entwickelt wurde
kann."„Trotz bedeutender Fortschritte in der Atemwegsmedizin ist schweres Asthma für viele Menschen nach wie vor schwer zu kontrollieren", sagte Dr. Laurie Lee, Chief Medical Officer für Immunologie und Entzündungen bei Generate:Biomedicines „Die Einleitung der Phase-3-Studien für GB-0895 spiegelt sowohl unser
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines deve iniciar estudos globais de Fase 3 do GB-0895, um anticorpo anti-TSLP de ação prolongada para asma grave desenvolvido com IA
anos.""Apesar dos avanços significativos na medicina respiratória, a asma grave continua sendo difícil de controlar para muitas pessoas", disse Laurie Lee, MD, diretora médica de imunologia e inflamação da Generate:Biomedicines. "O início dos estudos de Fase 3 para o GB-0895 reflete nosso compromisso com
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines inicia estudios globales de fase 3 de GB-0895
pesar de los importantes avances en medicina respiratoria, el asma grave sigue siendo difícil de controlar para muchas personas", afirmó el Dr. Laurie Lee, director médico de inmunología e inflamación de Generate:Biomedicines. "El inicio de los estudios de fase 3 para GB-0895 refleja tanto nuestro compromiso
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines iniciará ensayos clínicos de fase 3 a nivel mundial del GB-0895, un anticuerpo anti-TSLP de acción prolongada para el asma grave diseñado con IA
pesar de los importantes avances en medicina respiratoria, el asma grave sigue siendo difícil de controlar para muchas personas", comentó la Dra. Laurie Lee, directora médica de Inmunología e Inflamación de Generate:Biomedicines. "Comenzar los ensayos de fase 3 del GB-0895 refleja tanto nuestro compromiso
More news about: Generate:Biomedicines
Nov 30, 2025, 00:47 ET AUTOCRYPT kündigt Pläne zur Ausweitung der Cybersecurity-Technologien für Elektrofahrzeuge auf die MENA-Region im Jahr 2026 an
diese Region zu expandieren, in der die nächste Generation von Cybersicherheitsarchitekturen für Elektrofahrzeuge schnell Einzug hält", sagte Seokwoo Lee, Gründer und Geschäftsführer von AUTOCRYPT. „Wir haben schon immer einen ganzheitlichen Ansatz für die Cybersicherheit von Fahrzeugen mit unseren proprietären
More news about: AUTOCRYPT
Nov 29, 2025, 21:54 ET Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery
in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, HESAI, UBTech, WeRide, HyperStrong, Insta360, Unisound, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, AusperBio, Yuanxin Technology,
More news about: Qiming Venture Partners
Nov 29, 2025, 18:12 ET Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery
in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, HESAI, UBTech, WeRide, HyperStrong, Insta360, Unisound, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, AusperBio, Yuanxin Technology,
More news about: Qiming Venture Partners
Nov 29, 2025, 11:00 ET VEVOR Powers Black Friday Growth and Lights Up Times Square with Immersive Pop-Up
I no longer use and see them transformed into art was incredible. It made me feel part of a truly creative and sustainable community," said Jessica Lee, a Brooklyn resident and DIY enthusiast who participated in the event.During the activation, VEVOR also announced the launch of the VEVOR Home
More news about: Vevor
Nov 28, 2025, 21:19 ET 만다이 레인포레스트 리조트 바이 반얀트리 그랜드 오픈 및 레인포레스트 페스티벌 개최
건축사무소의 설립자 웡 치우 만(Wong Chiu Man)이 참여했다.오프닝 첫날 행사는 그동안 함께 노력해 준 파트너와 협력사에 감사를 전하는 만찬으로 마무리되었다. 이날 저녁 행사는 폴 포스터(Paul Foste)의 사회로 진행되었으며, 민 리 (Min Lee), 울프강 바이올린 스튜디오(Wolfgang Violin Studio)의 어린이 단원들, 작곡가 겸 가수 샤자(Shazza), 보컬 밴드 미카펠라(MICappella), 그리고 딕 리 (Dick Lee)의 공연이 이어졌다. 특히, 딕 리(Dick Lee)가 선보인 자작곡
More news about: Banyan Group
Nov 28, 2025, 14:10 ET AUTOCRYPT annonce son intention d'étendre ses technologies de cybersécurité des véhicules électriques à la région MENA en 2026
dans cette région, qui adopte rapidement des architectures de cybersécurité de nouvelle génération pour les véhicules électriques », a déclaré Seokwoo Lee, fondateur et PDG d'AUTOCRYPT. « Nous avons toujours adopté une approche globale de la cybersécurité des véhicules grâce à nos technologies exclusives
More news about: AUTOCRYPT
Nov 28, 2025, 10:00 ET RG Barry Brands and Green Market Services Announce Intent to Pursue Asset Acquisition
lead Clarks and Timberland into the next chapter of their slipper journey, serving today's consumer and strengthening long-term brand value."Lee Smith, President of Columbus Product Group and a 20-year veteran of RG Barry Brands, will oversee both brands and lead the GMS integration. Smith shared,
More news about: RG Barry Brands
Nov 28, 2025, 09:49 ET AUTOCRYPT expandirá las tecnologías de ciberseguridad de vehículos eléctricos a la región MENA
expandirnos a esta región, que está adoptando rápidamente arquitecturas de ciberseguridad de última generación en vehículos eléctricos", afirmó Seokwoo Lee, fundador y consejero delegado de AUTOCRYPT. "Siempre hemos adoptado un enfoque holístico en la ciberseguridad vehicular con nuestras tecnologías patentadas
More news about: AUTOCRYPT